drug discovery Apr 13, 2022 Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research Apr 7, 2022 Ensem Therapeutics Raises $67M in Series A Financing Dec 9, 2021 Microsoft, M2Gen Collaborate on Oncology Analytics for Drug Discovery Nov 16, 2021 Sotio Biotech Licenses LegoChem Biosciences ADC Platform in $1.03B Deal Mar 17, 2021 M2Gen Lands New Private Investment, Inks Research Deal with Merck Jun 11, 2020 Seven Bridges Building Research Platform for PanCAN Sep 30, 2019 Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO Sep 10, 2019 Repare Therapeutics Using CRISPR to Develop Cancer Treatments for Synthetic Lethal Targets Premium May 1, 2019 Kiyatec Raises $3M in Series B2 Funding Round Breaking News Enhertu Shows Activity in Early-Stage HER2-Low Breast Cancer Patients in Study Reported at SABCS Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody
